Cargando…

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) is associated with a frequent loss in ARID1A function. ARID1A reportedly suppresses histone deacetylase (HDAC)6 in OCCC directly. Here, we evaluated the clinical significance of HDAC6 expression and its related factors in terms of ARID1A status. Immunohistochemica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yano, Mitsutake, Katoh, Tomomi, Miyazawa, Mariko, Miyazawa, Masaki, Ogane, Naoki, Miwa, Maiko, Hasegawa, Kosei, Narahara, Hisashi, Yasuda, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382831/ https://www.ncbi.nlm.nih.gov/pubmed/30787326 http://dx.doi.org/10.1038/s41598-019-38653-0

Ejemplares similares

Association of histone deacetylase expression with histology and prognosis of ovarian cancer
por: Yano, Mitsutake, et al.
Publicado: (2018)

Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
por: Suzuki, Hiroyuki, et al.
Publicado: (2019)

Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma
por: Zaitsu, Sumika, et al.
Publicado: (2023)

Preponderance of endometrial carcinoma in elderly patients
por: Ogane, Naoki, et al.
Publicado: (2018)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019)

A unique uterine cervical “teratocarcinosarcoma”: a case report
por: Ito, Kozue, et al.
Publicado: (2019)

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
por: Heong, Valerie, et al.
Publicado: (2021)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019)

Uterine intravenous leiomyomatosis with an isolated large metastasis to the right atrium: a case report
por: Yano, Mitsutake, et al.
Publicado: (2020)

The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus
por: Sakaki, Mika, et al.
Publicado: (2017)

Endometrial intraepithelial carcinoma in association with polyp: review of eight cases
por: Yasuda, Masanori, et al.
Publicado: (2013)

An Unusual Ovarian Mucinous Borderline Tumor with a Large Solid Component
por: Kozawa, Eito, et al.
Publicado: (2019)

Estrogen-producing endometrioid adenocarcinoma resembling sex cord-stromal tumor of the ovary: a review of four postmenopausal cases
por: Katoh, Tomomi, et al.
Publicado: (2012)

Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report
por: Yano, Mitsutake, et al.
Publicado: (2018)

Synchronous mucinous metaplasia and neoplasia of the female genital tract with external urethral meatus neoplasm: A case report
por: Ikeda, Yuji, et al.
Publicado: (2015)

Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
por: Harasawa, Makiko, et al.
Publicado: (2011)

Functioning Endometrium and Endometrioma in a Patient with Mayer-Rokitanski-Kuster-Hauser Syndrome
por: Kawano, Yasushi, et al.
Publicado: (2014)

A Case of Vaginal Malignant Melanoma Completely Resected by Radical Surgery
por: Tokumitsu, Ryuichi, et al.
Publicado: (2020)

Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features
por: Miyazawa, Masaki, et al.
Publicado: (2016)

Wisteria floribunda agglutinin-binding glycan expression is decreased in endometriomata
por: Hirakawa, Tomoko, et al.
Publicado: (2014)

Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
por: Shida, Masako, et al.
Publicado: (2016)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Clinicopathological Significance of the ET Axis in Human Oral Squamous Cell Carcinoma
por: Miyazawa, Hiroki, et al.
Publicado: (2018)

Mouse APOBEC3 affects the production of virus-neutralizing antibodies by restricting early retroviral replication, not by altering the B-cell repertoire
por: Miyazawa, Masaaki, et al.
Publicado: (2009)

The role of nutrition and oxidative stress as aging factors in Caenorhabditis elegans
por: Yasuda, Kayo, et al.
Publicado: (2023)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
por: Fukumoto, Takeshi, et al.
Publicado: (2018)

ARID1A-mutated ovarian cancers depend on HDAC6 activity
por: Bitler, Benjamin G., et al.
Publicado: (2017)

Thoracic mesenchymal malignant tumors and programed cell death ligand‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas
por: Otsubo, Kanji, et al.
Publicado: (2021)

Complete remission of diabetes with a transient HDAC inhibitor and insulin in streptozotocin mice
por: Kojima, Hideto, et al.
Publicado: (2023)

A hole in the T-cell repertoire induced after retroviral infection of immunocompetent adult mice
por: Miyazawa, Masaaki, et al.
Publicado: (2011)

ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma
por: Megino‐Luque, Cristina, et al.
Publicado: (2022)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Significance of PD-L1 Expression in Tongue Cancer Development
por: Yoshida, Saori, et al.
Publicado: (2018)

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment
por: Fadare, Oluwole, et al.
Publicado: (2012)

An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression: Its Application for Refractory Ovarian Cancer
por: Fujita, Mariko, et al.
Publicado: (2007)

Evidence for a novel antioxidant function and isoform-specific regulation of the human p66Shc gene
por: Miyazawa, Masaki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_85glc5v0be5kd65bifhrbfevv9